Although co-administration of transport inhibitors together with the actual anticancer drug may enhance drug penetration into the tumour [24], no real solution to multidrug resistance has been found to date and no chemical P-gp inhibitors with clinically satisfying results have been described mainly due to their high toxicity [23, 24]. The gene discussed is PGP; the disease is neoplasm.